ArticleJournal of orthopaedic case reports2025
The Giant Cell Tumor of 1st Metatarsal in a Young Adult: A Rare Versatile Management with Fibula Cortical Graft.
Article in Journal of orthopaedic case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Giant cell tumor is a benign aggressive tumor commonly affecting the 2nd decade. Most commonly seen in the ends of long bones like the distal femur, proximal tibia, distal radius, and proximal humerus, but it does occur in small bones like hands and feet in <2%. Case Report: A young female adult of age 23 has been diagnosed with a giant cell tumor of her 1st metatarsal and underwent complete excision with reconstruction with non-vascularized autogenous cortical fibula strut graft using a reconstruction plate and screws and 1-year follow-up showed a good graft union and no signs of recurrence. Conclusion: Local resection of the affected metatarsal combined with chemoablation reduces recurrence risk, while a fibula graft offers structural stability. In our case, there were no signs of recurrence, and the graft showed good incorporation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.